Related Experiment Video
Updated: Jul 11, 2026
04:46
A Modified Transcranial Middle Cerebral Artery Occlusion Model to Study Stroke Outcomes in Aged Mice
Published on: May 5, 2023
The PRoFESS trial: future impact on secondary stroke prevention
1University Duisburg-Essen, Department of Neurology, Hufelandstrasse 55, 45122 Essen, Germany. h.diener@uni-essen.de
Expert Review of Neurotherapeutics
|September 18, 2007
Summary
Patients at high risk for recurrent stroke benefit from combination therapies like aspirin with extended-release dipyridamole or clopidogrel. The PRoFESS trial investigates these and renin-angiotensin system blockers for secondary stroke prevention.
Area of Science:
- Neurology
- Cardiology
- Clinical Trials
Background:
- Patients with transient ischemic attack (TIA) and ischemic stroke face significant risks of recurrent events and mortality.
- Aspirin is a standard therapy, but recent evidence suggests combination treatments may offer superior protection.
- Renin-angiotensin system inhibitors are also being explored for their potential to reduce stroke recurrence.
Purpose of the Study:
- To compare the efficacy of extended-release dipyridamole plus aspirin versus clopidogrel in preventing recurrent strokes.
- To evaluate the added benefit of telmisartan to usual care in post-stroke patients.
- To assess the safety profiles of the investigated treatment strategies.
Main Methods:
- The Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial is a large, multicenter, randomized, double-blind study.
- Over 20,000 patients were enrolled across 695 sites in 35 countries.
- A 2x2 factorial design was employed to simultaneously assess multiple treatment arms, with recurrent stroke as the primary outcome.
Main Results:
- The study aimed to determine if specific combination therapies significantly reduce the risk of recurrent stroke compared to other standard or investigational treatments.
- Safety outcomes, including major hemorrhage and other serious adverse events, were rigorously monitored.
- The PRoFESS trial represents a landmark effort in stroke prevention research due to its scale and design.
Conclusions:
- Findings from the PRoFESS trial are expected to inform clinical guidelines for secondary stroke prevention.
- The study will provide crucial data on the comparative effectiveness and safety of different antiplatelet and antihypertensive strategies.
- This research is vital for optimizing patient care and reducing the burden of recurrent strokes.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:27Regulation of Stroke Volume
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...